-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 29, the Shenzhen Stock Exchange issued the "Letter on Supervision to Du Xianju, Director and Senior Manager of Ogilvy Medical Products Co.
, Ltd.
"
.
The supervisory letter stated that Du Xianju, as the director, vice president and secretary of the board of directors of Ogilvy Medical, and his child Du Kaiwen frequently bought and sold company stocks from July 6 to August 5, 2020, and bought 54100 shares of company stock in total.
From the data point of view, Ogilvy Medical Director and Vice President Du Xianju’s son Du Kaiwen did not make any profit in the above transaction, but lost 35,700 yuan
.
Ogilvy Medical’s previous prospectus indicated that Du Kaiwen was born in 1992 and has no position in the company
The Shenzhen Stock Exchange pointed out that Du Xianju, as a director and senior manager of the company, failed to urge his children to compliantly trade company stocks, and violated Article 1.
4 of the Shenzhen Stock Exchange’s "Stock Listing Rules (Revised in November 2018)" and the "Guidelines for the Normative Operation of Listed Companies (" Revised in 2020)" Article 3.
8.
1 and Article 3.
8.
13
.
Please pay full attention to the above-mentioned problems, learn lessons, and make timely corrections to prevent the above-mentioned problems from recurring
On May 31, Ogilvy Medical issued an apology for this
.
Ogilvy Medical stated that Du Xianju did not know about the stock trading of his children, Du Kaiwen, and never informed his children about the company’s operations or other inside information.
Ogilvy & Mather Medical stated that Du Xianju is deeply self-blame for failing to fulfill the supervision obligations in a timely manner.
